Anti-SARS-CoV-2 Tests: Manufacturer independent IgG and IgM controls available

SARS-CoV-2 antibody assays from numerous suppliers worldwide are currently being sold without corresponding internal quality controls – mainly due to the lack of available positive plasma on the market.
The controls are important to assess laboratory precision and day-to-day assay performance of the testing systems.

To fill this gap, DiaMex GmbH (a sister company of BIOMEX) has developed an Anti-SARS-CoV-2 IgG and IgM control to be used with several different assays. The controls

– are human plasma-based to mimic patient specimen encountered in a daily testing environment and provide a complete quality solution for SARS-CoV-2 #antibody testing,
– react at an appropriate level within the analytical range of the assays with a high lot to lot consistency,
– can be used as third party controls to verify systematic errors and satisfy regulatory guidelines for use of independent controls.

For further information please contact the

This site is registered on as a development site.